The impact of haemostatic agent used during robot-assisted radical prostatectomy on post-op infection and anastomotic leak

IF 1.9 Q3 UROLOGY & NEPHROLOGY
BJUI compass Pub Date : 2025-07-02 DOI:10.1002/bco2.70023
Jamie Krishnan, Rory Brennan, Osman El-Koubani, Sailantra Sivathasan, Kevin Gallagher, Linda Taylor, Abhishek Sharma, Daniel Good, Alan McNeill
{"title":"The impact of haemostatic agent used during robot-assisted radical prostatectomy on post-op infection and anastomotic leak","authors":"Jamie Krishnan,&nbsp;Rory Brennan,&nbsp;Osman El-Koubani,&nbsp;Sailantra Sivathasan,&nbsp;Kevin Gallagher,&nbsp;Linda Taylor,&nbsp;Abhishek Sharma,&nbsp;Daniel Good,&nbsp;Alan McNeill","doi":"10.1002/bco2.70023","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>Despite the widespread use of robotic-assisted radical prostatectomy (RARP), considerable variation exists in practice with regard to postoperative cystograms prior to trial without catheter (TWOC).</p>\n \n <p>Our practice was to undertake a cystogram at 7–14-day post-op and proceed with TWOC if the leak was small or absent.</p>\n \n <p>In this study, we evaluate the risk factors for anastomotic leak and post-op urinary tract infection (UTI), while assessing the impact of using powdered haemostat Arista AH on post-op UTIs and cystographic leaks to rationalise the use of cystograms.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>The study was carried out in two phases, the first a retrospective review of 154 patients undergoing RARP between January and October 2022, where Oxitamp (an absorbable haemostat of oxidised regenerated cellulose) was used as the haemostatic agent.</p>\n \n <p>The second phase was prospective, involving 62 patients between November and June 2023, in whom the powdered haemostat Arista AH (microporous polysaccharide haemospheres) was used instead.</p>\n \n <p>Data were collated from a prospectively collected database (REDCap<sup>Ò</sup>) and electronic patient records. RARP was performed by two experienced surgeons using similar techniques. Analysis was carried out on R-studios, using Fisher's exact test for categorical variables and unpaired student <i>t</i>-test for continuous variables.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Post-op UTI occurred in 19 (12%) patients in Cohort 1 (with Oxitamp) and leaks were associated with 15 (79%). In comparison, seven (11%) patients in Cohort 2 (with Arista AH) suffered from post-op UTI, and only one (14%) was associated with leak.</p>\n \n <p>There was an overall reduction in leaks on post-op cystograms from 44 (29%) in Cohort 1 to only nine (15%) in Cohort 2 (<i>p</i> = 0.036).</p>\n \n <p>One hundred per cent of the leaks in Cohort 2 were small, compared to nine (20%) in Cohort 1 (<i>p</i> = 0.0002).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>A selective approach can be implemented with regard to post-op cystograms.</p>\n \n <p>We propose that when using Arista AH cystograms should be carried out in patients in need of bladder neck reconstruction. We will also continue to undertake routine cystograms in those with a history of transurethral resection of prostate (TURP) or in salvage prostatectomy cases.</p>\n </section>\n </div>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"6 7","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.70023","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJUI compass","FirstCategoryId":"1085","ListUrlMain":"https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.70023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Despite the widespread use of robotic-assisted radical prostatectomy (RARP), considerable variation exists in practice with regard to postoperative cystograms prior to trial without catheter (TWOC).

Our practice was to undertake a cystogram at 7–14-day post-op and proceed with TWOC if the leak was small or absent.

In this study, we evaluate the risk factors for anastomotic leak and post-op urinary tract infection (UTI), while assessing the impact of using powdered haemostat Arista AH on post-op UTIs and cystographic leaks to rationalise the use of cystograms.

Methods

The study was carried out in two phases, the first a retrospective review of 154 patients undergoing RARP between January and October 2022, where Oxitamp (an absorbable haemostat of oxidised regenerated cellulose) was used as the haemostatic agent.

The second phase was prospective, involving 62 patients between November and June 2023, in whom the powdered haemostat Arista AH (microporous polysaccharide haemospheres) was used instead.

Data were collated from a prospectively collected database (REDCapÒ) and electronic patient records. RARP was performed by two experienced surgeons using similar techniques. Analysis was carried out on R-studios, using Fisher's exact test for categorical variables and unpaired student t-test for continuous variables.

Results

Post-op UTI occurred in 19 (12%) patients in Cohort 1 (with Oxitamp) and leaks were associated with 15 (79%). In comparison, seven (11%) patients in Cohort 2 (with Arista AH) suffered from post-op UTI, and only one (14%) was associated with leak.

There was an overall reduction in leaks on post-op cystograms from 44 (29%) in Cohort 1 to only nine (15%) in Cohort 2 (p = 0.036).

One hundred per cent of the leaks in Cohort 2 were small, compared to nine (20%) in Cohort 1 (p = 0.0002).

Conclusions

A selective approach can be implemented with regard to post-op cystograms.

We propose that when using Arista AH cystograms should be carried out in patients in need of bladder neck reconstruction. We will also continue to undertake routine cystograms in those with a history of transurethral resection of prostate (TURP) or in salvage prostatectomy cases.

Abstract Image

Abstract Image

Abstract Image

机器人辅助前列腺根治术中使用止血剂对术后感染和吻合口漏的影响
目的:尽管机器人辅助根治性前列腺切除术(RARP)被广泛应用,但在实践中,术后无导管试验前膀胱造影(TWOC)存在相当大的差异。我们的做法是在术后7 - 14天进行膀胱造影,如果渗漏很小或没有,则进行TWOC。在本研究中,我们评估吻合口瘘和术后尿路感染(UTI)的危险因素,同时评估使用粉末状止血药Arista AH对术后尿路感染和膀胱造影泄漏的影响,以使膀胱造影的使用合理化。研究分两个阶段进行,第一个阶段是对2022年1月至10月期间接受RARP治疗的154例患者进行回顾性分析,其中使用Oxitamp(氧化再生纤维素的可吸收止血剂)作为止血剂。第二阶段是前瞻性的,在2023年11月至6月期间纳入62例患者,其中使用粉状止血药Arista AH(微孔多糖血球)代替。数据从前瞻性收集的数据库(REDCapÒ)和电子病历中整理。RARP由两位经验丰富的外科医生使用类似的技术进行。对r -studio进行分析,对分类变量使用Fisher精确检验,对连续变量使用unpaired student t检验。结果在队列1(使用Oxitamp)中,19例(12%)患者发生了术后尿路感染,15例(79%)患者发生了渗漏。相比之下,队列2 (Arista AH)中有7例(11%)患者出现术后尿路感染,只有1例(14%)患者出现尿漏。术后膀胱造影渗漏从队列1的44例(29%)减少到队列2的9例(15%)(p = 0.036)。队列2中100%的泄漏都很小,而队列1中只有9% (20%)(p = 0.0002)。结论术后膀胱造影可采用选择性方法。我们建议在使用Arista AH时对需要膀胱颈部重建的患者进行膀胱造影。我们也将继续对有经尿道前列腺切除术(TURP)病史的患者或补救性前列腺切除术患者进行常规膀胱造影检查。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.30
自引率
0.00%
发文量
0
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信